Navigation Links
ADVENTRX and FDA Reach Agreement on Pivotal Study for ANX-514
Date:10/26/2011

itute one-third of the patients who receive Taxotere."  

About Study 514-02

Study 514-02 will be a randomized, open-label, multicenter, non-inferiority study comparing ANX-514, administered without corticosteroid premedication, and Taxotere, administered with corticosteroid premedication, in the treatment of non-small cell lung cancer after failure of prior platinum-based therapy.  Approximately 400 patients will be enrolled and treated until evidence of progressive disease, unacceptable toxicity, withdrawal of consent, or other withdrawal criteria are met.  The primary objective will be to compare the incidence of fluid retention between study arms.  The secondary objectives will be to compare ANX-514 and Taxotere in terms of overall safety profile, objective response rate, duration of response, progression-free survival and overall survival.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on developing proprietary product candidates.  The Company's current lead product candidates are ANX-188, a novel, purified, rheologic and antithrombotic compound initially being developed as a first-in-class treatment for pediatric patients with sickle cell disease in acute crisis, and ANX-514, a detergent-free formulation of the blockbuster drug Taxotere®, which recently went off-patent.  The Company is seeking a partner or outside investor for its Exelbine program.  More information can be found on the Company's web site at www.adventrx.com.  

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding the design for,
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26
2. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
3. ADVENTRX Provides Update on All Three Pipeline Products
4. ADVENTRX Reports Second Quarter 2011 Financial Results
5. ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11
6. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
7. ADVENTRX Reports First Quarter 2011 Financial Results
8. ADVENTRX Completes Acquisition of SynthRx
9. ADVENTRX Pharmaceuticals Provides Update on ANX-514
10. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
11. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. ... in automated retailing, micro-stores, custom vending machines and ... their automated medicine dispensing systems, which can be ... clinics and marijuana dispensaries. AVT,s newly designed systems ... of medicines and regulated products. "We ...
(Date:7/21/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... Administration (FDA) accepted the company,s Investigational New Drug (IND) ... and efficacy of AVP-786, Avanir,s next generation compound. The ... the adjunctive treatment of major depressive disorder (MDD) during ... "The endorsement of this Phase II study by the ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4
... Patent Office has awarded COPAN the much awaited patent for ... samples. This grant, deriving from a very thorough and careful ... flocked swab invention. COPAN,s revolutionary invention has now been awarded ...   " We are thrilled to receive ...
... -- The Ministry of Health and Welfare (Minister ... Institute (President Ko Kyung-hwa) launched a project to ... by designating 38 tasks, including seven major issues ... injuries and granting permission for drug dispensing in ...
Cached Medicine Technology:US Patent Office Grants COPAN Invention of Flocked Swabs 2Medical Korea's Medical Policy Improvement Project for Foreign Patients 2
(Date:7/22/2014)... July 22, 2014 Get Real ... Immune Deficiency Foundation (IDF) to provide their ... that will allow them to electronically track their symptoms, ... their illnesses. It will also allow those patients and ... consent to have their data shared with the ...
(Date:7/22/2014)... 22, 2014 JumpSoft, Inc., a ... automated recovery at the application level, today released ... to application-centric management. , Based on ... the report provides insights, context and depth regarding ... application and system uptime. London, Ink, a B2B ...
(Date:7/22/2014)... Recently, MyDressCity.com has excitedly launched a promotion ... moment, all people can get a discount, up to 60% ... in the new range; all the new items are of ... prettiest Quinceanera gowns for worldwide clients. Our dress specialists are ... CEO of MyDressCity.com, “Our Quinceanera dresses are selling well in ...
(Date:7/22/2014)... NY (PRWEB) July 22, 2014 BlackBox ... Blast Gauge™ System with advancements including a ... The new gauges represent a functional revision of the ... capability to capture complex data on blast events by ... resulting accelerations. The extreme changes in overpressure that accompany ...
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person ... important books young people can read. , But be careful! What’s ... the “truths” people have been living with all their lives. And ... be? From sex to death, this self-help book deals directly with ... it tells it like it is. , Tune in to “The ...
Breaking Medicine News(10 mins):Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 3Health News:Beautiful Dama Dresses Now Released By Popular Online Supplier MyDressCity.com 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 3Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2
... San Diego Moores Cancer Center researchers and surgeons are ... with recurrent brain cancer by directly injecting an investigational ... developed by a local San Diego Company, Tocagen Inc. ... the deadliest forms of brain tumor," said principal investigator ...
... nutrient found in the dark meat of poultry may provide ... cholesterol, according to a study by researchers at NYU Langone ... European Journal of Nutrition , evaluated the effects of ... turkey and chicken, as well as in some fish and ...
... , THURSDAY, March 1 (HealthDay News) - Here,s one more ... you are an older woman: A new study found a ... ate the highest amount of this common ingredient in baked ... at the University of North Carolina in Chapel Hill, did ...
... A team of 18 researchers at Moffitt Cancer Center ... sarcoma patients with a combination of implanted dendritic cells (immune ... than 50 percent of their trial patients with tumor-specific immune ... study was published in a recent issue of the ...
... 1, 2012) Imaging amino acid transporters with ... to significantly alter intended management plans for patients ... March issue of The Journal of Nuclear ... the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), physicians changed the intended ...
... of leukaemia treatment and survival in Northern Ireland by the ... survival rates for the disease here are at the highest ... children with the disease, survival has improved dramatically from under ... level of over 80 per cent for five year survival. ...
Cached Medicine News:Health News:UC San Diego among first in nation to treat brain cancer with novel viral vector 2Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 2Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 3Health News:Trans Fats May Raise Stroke Risk in Older Women 2Health News:Trans Fats May Raise Stroke Risk in Older Women 3Health News:Researchers find sarcoma tumor immune response with combination therapy 2Health News:PET tracer changes management plan for brain tumor patients 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 3
... facilitates real time information collection. It ... first module is a software link ... the database where information is captured ... the user interface, which allows access ...
... provides a solution for instantaneously locating ... or unauthorized movement of patients or ... key concern. Certain patients, such as ... patients with highly communicable diseases, patients ...
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
PDC RFID Smart™ Cards can be printed and programmed using a dye-sublimation card printer & programmer....
Medicine Products: